On the one hand, silencing of FAAH inhibited the malignant progression of GC in three ways: blocking tumour suppressor signal AEA degradation, providing PE for the synthesis of AEA, and inhibiting downstream AA/COX-2/PGE2 signal activation. The gene discussed is PTGS2; the disease is gastric cancer.